Suspension of trading

Income Statement YMAS THER

Stocks

YMAB

US9842411095

Market Closed - NYSE 16:00:00 2025-09-15 EDT			5-day change	1st Jan Change
8.610 ^USD	+0.23%		-.--%	-

25-09-17	Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Index	CI
25-09-17	Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Index	CI

ce56cb74ad5313c17.kHzXQtRnTskF5M7JSajco0lowk8yx49rAt6DXhIqgsc.6E_mcbcwPoZ9gr27A8y_1BExiXdmtcFaMYTRHSZGsKKlLrgEulAcrHSFlw

Published financial data: YMAS THER

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	20.75M	34.9M	65.27M	84.82M	87.68M
Total Revenues	20.75M	34.9M	65.27M	84.82M	87.68M
Cost of Goods Sold, Total	2.2M	2.51M	7.57M	11.42M	15.25M
Gross Profit	18.55M	32.38M	57.7M	73.4M	72.43M
Selling General & Admin Expenses, Total	45.9M	56.94M	52.47M	44.5M	50.13M
R&D Expenses	92.58M	90.88M	88.55M	50.09M	47.41M
Other Operating Expenses, Total	138M	148M	141M	94.59M	97.54M
Operating Income	-120M	-115M	-83.32M	-21.19M	-25.11M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	22K	45K	643K	4.81M	3.43M
Net Interest Expenses	22K	45K	643K	4.81M	3.43M
Currency Exchange Gains (Loss)	576K	-1.9M	-	-	-2.04M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-119M	-117M	-82.68M	-16.38M	-23.72M
Restructuring Charges	-	-	-	-4.48M	-1.52M
Gain (Loss) On Sale Of Assets	-	62.01M	-	-	-
Asset Writedown	-	-	-617K	-	-
Legal Settlements	-	-	-	-	-3.85M
Other Unusual Items	-	-	-12.28M	-	-718K
EBT, Incl. Unusual Items	-119M	-55.28M	-95.57M	-20.87M	-29.81M
Income Tax Expense	-	-	-	561K	-146K
Earnings From Continuing Operations	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Net Income to Company	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Net Income - (IS)	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Net Income to Common Incl Extra Items	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Net Income to Common Excl. Extra Items	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Per Share Items
Net EPS - Basic	-2.97	-1.28	-2.19	-0.49	-0.67
Basic EPS - Continuing Operations	-2.97	-1.28	-2.19	-0.49	-0.67
Basic Weighted Average Shares Outstanding	40.12M	43.18M	43.7M	43.65M	44.33M
Net EPS - Diluted	-2.97	-1.28	-2.19	-0.49	-0.67
Diluted EPS - Continuing Operations	-2.97	-1.28	-2.19	-0.49	-0.67
Diluted Weighted Average Shares Outstanding	40.12M	43.18M	43.7M	43.65M	44.33M
Normalized Basic EPS	-1.86	-1.7	-1.18	-0.23	-0.33
Normalized Diluted EPS	-1.86	-1.7	-1.18	-0.23	-0.33
Supplemental Items
EBITDA	-120M	-115M	-82.48M	-20.46M	-24.58M
EBITA	-120M	-115M	-83.32M	-21.19M	-25.11M
EBIT	-120M	-115M	-83.32M	-21.19M	-25.11M
EBITDAR	-118M	-112M	-79.83M	-19.42M	-23.59M
Total Revenues (As Reported)	-	34.9M	65.27M	84.82M	87.68M
Effective Tax Rate - (Ratio)	-	-	-	-2.69	0.49
Current Domestic Taxes	-	-	-	561K	-146K
Total Current Taxes	-	-	-	561K	-146K
Normalized Net Income	-74.59M	-73.3M	-51.67M	-10.24M	-14.83M
Supplemental Operating Expense Items
General and Administrative Expenses	44.58M	-	-	-	-
Research And Development Expense From Footnotes	93.7M	93.24M	91.57M	54.22M	48.99M
Net Rental Expense, Total	1.32M	2.61M	2.65M	1.03M	982K
Stock-Based Comp., R&D Exp. (Total)	7.57M	7.4M	7.83M	8.41M	5.46M
Stock-Based Comp., G&A Exp. (Total)	8.56M	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	11.93M	17.77M	6.04M	9.1M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	16.14M	19.33M	25.6M	14.45M	14.56M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	115M	182M	106M	78.64M	67.23M
Total Cash And Short Term Investments	115M	182M	106M	78.64M	67.23M
Accounts Receivable, Total	800K	7.71M	12.53M	22.45M	19.69M
Total Receivables	800K	7.71M	12.53M	22.45M	19.69M
Inventory	-	5.51M	6.7M	5.06M	7.21M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	6.93M	7.47M	5.45M	4.96M	4.37M
Total Current Assets	122M	202M	130M	111M	98.51M
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	6.39M	5.69M	2.34M	1.64M	859K
Other Intangibles, Total	-	1.66M	2.99M	2.63M	2.28M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	3.29M	3.17M	5.68M	12.49M	18.26M
Total Assets	132M	213M	141M	128M	120M
Liabilities
Accounts Payable, Total	9.37M	13.55M	14.18M	6.06M	6.66M
Accrued Expenses, Total	4.59M	6.84M	6.76M	7.4M	8.18M
Current Portion of Leases	1.97M	1.78M	868K	902K	630K
Other Current Liabilities	3.61M	5.7M	6.48M	5.76M	8.22M
Total Current Liabilities	19.54M	27.88M	28.28M	20.13M	23.7M
Long-Term Leases	2.01M	1.85M	899K	517K	190K
Other Non Current Liabilities	4.66M	2.95M	3.05M	6.24M	4.01M
Total Liabilities	26.21M	32.68M	32.24M	26.88M	27.9M
Common Stock, Total	4K	4K	4K	4K	4K
Additional Paid In Capital	392M	519M	544M	558M	577M
Retained Earnings	-285M	-340M	-436M	-457M	-487M
Comprehensive Income and Other	-526K	1.37M	1.33M	449K	2.26M
Total Common Equity	106M	180M	109M	101M	92M
Total Equity	106M	180M	109M	101M	92M
Total Liabilities And Equity	132M	213M	141M	128M	120M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	43.53M	43.71M	43.68M	43.78M	45.22M
ECS Total Common Shares Outstanding	40.69M	43.69M	43.67M	43.67M	44.99M
Book Value / Share	2.6	4.12	2.5	2.31	2.05
Tangible Book Value	106M	178M	106M	98.35M	89.73M
Tangible Book Value Per Share	2.6	4.08	2.43	2.25	1.99
Total Debt	3.98M	3.63M	1.77M	1.42M	820K
Net Debt	-111M	-178M	-104M	-77.22M	-66.41M
Debt Equivalent Oper. Leases	10.59M	20.86M	21.17M	8.26M	7.86M
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Work In Process, Total	-	4.74M	6.04M	2.07M	-
Inventories - Finished Goods, Total	-	771K	666K	2.99M	2.28M
Inventories - Others	-	-	-	-	4.94M
Full Time Employees	125	148	147	100	104
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	508K	492K	626K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-119M	-55.28M	-95.57M	-21.43M	-29.67M
Depreciation & Amortization - CF	396K	645K	839K	735K	535K
Amortization of Goodwill and Intangible Assets - (CF)	-	137K	-	-	-
Depreciation & Amortization, Total	396K	782K	839K	735K	535K
(Gain) Loss From Sale Of Asset	-	-62.01M	-	-	-
Stock-Based Compensation (CF)	16.14M	19.33M	25.6M	14.45M	14.56M
Provision and Write-off of Bad Debts	-	-	-	-	520K
Other Operating Activities, Total	8.13M	1.9M	3.58M	-1.26M	1.99M
Change In Accounts Receivable	-	-7.71M	-4.82M	-9.92M	2.25M
Change In Inventories	-	-5.51M	-1.19M	1.64M	-2.15M
Change In Accounts Payable	852K	4.18M	-919K	-6.86M	-1.38M
Change in Other Net Operating Assets	2.59M	1.76M	-3.44M	-4.59M	-2.36M
Cash from Operations	-91.23M	-103M	-75.92M	-27.23M	-15.71M
Capital Expenditure	-175K	-667K	-	-	-
Sale of Property, Plant, and Equipment	-	62.01M	-	-	-
Sale (Purchase) of Intangible assets	-	-300K	-	-	-
Other Investing Activities, Total	-2.61M	-	-	-	-
Cash from Investing	-2.78M	61.04M	-	-	-
Issuance of Common Stock	2M	108M	84K	100K	4.31M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	2M	108M	84K	100K	4.31M
Foreign Exchange Rate Adjustments	-490K	129K	35K	7K	-
Net Change in Cash	-92.5M	66.93M	-75.8M	-27.12M	-11.4M
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	367K	713K
Levered Free Cash Flow	-57.01M	-57.44M	-28.3M	-14.03M	4.44M
Unlevered Free Cash Flow	-57.01M	-57.44M	-28.3M	-14.03M	4.44M
Change In Net Working Capital	-1.59M	4.44M	2.66M	15.98M	-5.04M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-43.03	-41.84	-29.4	-9.83	-12.67
Return on Total Capital	-48.21	-49.15	-35.34	-12.41	-16.08
Return On Equity %	-78.32	-38.66	-66.06	-20.39	-30.74
Return on Common Equity	-78.32	-38.66	-66.06	-20.39	-30.74
Margin Analysis
Gross Profit Margin %	89.38	92.8	88.41	86.54	82.61
SG&A Margin	221.2	163.16	80.39	52.46	57.17
EBITDA Margin %	-576.09	-328.54	-126.37	-24.12	-28.03
EBITA Margin %	-578	-330.39	-127.66	-24.98	-28.64
EBIT Margin %	-578	-330.78	-127.66	-24.98	-28.64
Income From Continuing Operations Margin %	-575.12	-158.39	-146.43	-25.26	-33.83
Net Income Margin %	-575.12	-158.39	-146.43	-25.26	-33.83
Net Avail. For Common Margin %	-575.12	-158.39	-146.43	-25.26	-33.83
Normalized Net Income Margin	-359.45	-210.06	-79.17	-12.07	-16.91
Levered Free Cash Flow Margin	-274.76	-164.6	-43.35	-16.55	5.06
Unlevered Free Cash Flow Margin	-274.76	-164.6	-43.35	-16.55	5.06
Asset Turnover
Asset Turnover	0.12	0.2	0.37	0.63	0.71
Fixed Assets Turnover	3.98	5.78	16.25	42.63	70.29
Receivables Turnover (Average Receivables)	-	-	6.45	4.85	4.16
Inventory Turnover (Average Inventory)	-	-	1.24	1.94	2.48
Short Term Liquidity
Current Ratio	6.26	7.26	4.61	5.52	4.16
Quick Ratio	5.91	6.79	4.18	5.02	3.67
Operating Cash Flow to Current Liabilities	-4.67	-3.68	-2.68	-1.35	-0.66
Days Sales Outstanding (Average Receivables)	-	-	56.6	75.28	87.95
Days Outstanding Inventory (Average Inventory)	-	-	294.58	188.11	147.34
Average Days Payable Outstanding	1.49K	-	577.84	377.63	133.8
Cash Conversion Cycle (Average Days)	-	-	-226.66	-114.25	101.49
Long Term Solvency
Total Debt/Equity	3.76	2.02	1.62	1.41	0.89
Total Debt / Total Capital	3.62	1.98	1.59	1.39	0.88
LT Debt/Equity	1.9	1.03	0.82	0.51	0.21
Long-Term Debt / Total Capital	1.83	1.01	0.81	0.5	0.2
Total Liabilities / Total Assets	19.85	15.36	22.79	21.02	23.27
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0.03	-0.03	-0.02	-0.07	-0.03
Net Debt / EBITDA	0.94	1.59	1.3	3.98	2.81
Total Debt / (EBITDA - Capex)	-0.03	-0.03	-0.02	-0.07	-0.03
Net Debt / (EBITDA - Capex)	0.93	1.58	1.3	3.98	2.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	68.18	87.03	29.96	3.38
Gross Profit, 1 Yr. Growth %	-	74.6	78.18	27.21	-1.32
EBITDA, 1 Yr. Growth %	44.3	-4.09	-28.06	-75.2	20.14
EBITA, 1 Yr. Growth %	44.49	-3.87	-27.73	-74.57	18.5
EBIT, 1 Yr. Growth %	44.49	-3.75	-27.82	-74.57	18.5
Earnings From Cont. Operations, 1 Yr. Growth %	47.28	-53.68	72.9	-77.58	38.45
Net Income, 1 Yr. Growth %	47.28	-53.68	72.9	-77.58	38.45
Normalized Net Income, 1 Yr. Growth %	47.28	-1.72	-29.51	-80.18	44.78
Diluted EPS Before Extra, 1 Yr. Growth %	29.16	-56.97	70.83	-77.55	36.47
Accounts Receivable, 1 Yr. Growth %	-	-	62.49	79.19	-12.32
Inventory, 1 Yr. Growth %	-	-	21.59	-24.43	42.43
Net Property, Plant and Equip., 1 Yr. Growth %	58.23	-11.03	-58.82	-30.18	-47.49
Total Assets, 1 Yr. Growth %	-38.97	61.14	-33.52	-9.61	-6.23
Tangible Book Value, 1 Yr. Growth %	-46.79	68.6	-40.47	-7.42	-8.77
Common Equity, 1 Yr. Growth %	-46.79	70.17	-39.36	-7.54	-8.89
Cash From Operations, 1 Yr. Growth %	24.13	12.41	-25.97	-64.13	-42.3
Capital Expenditures, 1 Yr. Growth %	-91.09	281.14	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	23.4	0.75	-51.71	-50.4	-131.64
Unlevered Free Cash Flow, 1 Yr. Growth %	23.4	0.75	-50.74	-50.4	-131.64
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	77.35	55.9	15.91
Gross Profit, 2 Yr. CAGR %	-	-	76.38	50.56	12.04
EBITDA, 2 Yr. CAGR %	66.34	17.65	-16.93	-57.76	-45.42
EBITA, 2 Yr. CAGR %	66.56	17.86	-16.65	-57.13	-45.1
EBIT, 2 Yr. CAGR %	66.56	17.93	-16.65	-57.16	-45.1
Earnings From Cont. Operations, 2 Yr. CAGR %	66.06	-17.41	-10.51	-37.74	-44.28
Net Income, 2 Yr. CAGR %	66.06	-17.41	-10.51	-37.74	-44.28
Normalized Net Income, 2 Yr. CAGR %	66.06	20.31	-16.77	-62.62	-46.44
Diluted EPS Before Extra, 2 Yr. CAGR %	40.63	-25.45	-14.26	-38.07	-44.65
Accounts Receivable, 2 Yr. CAGR %	-	-	-	70.63	25.35
Inventory, 2 Yr. CAGR %	-	-	-	-4.14	3.75
Net Property, Plant and Equip., 2 Yr. CAGR %	458.48	18.65	-39.47	-46.37	-39.45
Total Assets, 2 Yr. CAGR %	-6.77	-0.83	3.5	-22.48	-7.93
Tangible Book Value, 2 Yr. CAGR %	-13.22	-5.28	0.19	-25.76	-8.1
Common Equity, 2 Yr. CAGR %	-13.22	-4.84	1.59	-25.12	-8.22
Cash From Operations, 2 Yr. CAGR %	48.75	18.13	-8.78	-48.47	-54.51
Capital Expenditures, 2 Yr. CAGR %	-13.52	-41.74	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	45.64	11.51	-29.55	-51.06	-60.38
Unlevered Free Cash Flow, 2 Yr. CAGR %	45.64	11.51	-29.55	-50.57	-60.38
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	59.89	35.95
Gross Profit, 3 Yr. CAGR %	-	-	-	58.18	30.78
EBITDA, 3 Yr. CAGR %	-	38.45	-0.14	-44.48	-40.15
EBITA, 3 Yr. CAGR %	84.03	38.68	0.13	-43.89	-39.84
EBIT, 3 Yr. CAGR %	84.03	38.73	0.13	-43.89	-39.86
Earnings From Cont. Operations, 3 Yr. CAGR %	83.99	8.5	5.66	-43.58	-18.73
Net Income, 3 Yr. CAGR %	83.99	8.5	5.66	-43.58	-18.73
Normalized Net Income, 3 Yr. CAGR %	83.99	39.42	0.67	-48.41	-41.3
Diluted EPS Before Extra, 3 Yr. CAGR %	44.41	-5.23	-1.71	-45.15	-19.41
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	36.67
Inventory, 3 Yr. CAGR %	-	-	-	-	9.38
Net Property, Plant and Equip., 3 Yr. CAGR %	-	202.76	-16.61	-36.52	-46.75
Total Assets, 3 Yr. CAGR %	12.75	11.88	-13.21	-1.07	-17.4
Tangible Book Value, 3 Yr. CAGR %	8.81	8.29	-18.86	-2.41	-20.48
Common Equity, 3 Yr. CAGR %	8.81	8.62	-18.11	-1.55	-20.06
Cash From Operations, 3 Yr. CAGR %	79.14	35.49	1.09	-33.17	-46.49
Capital Expenditures, 3 Yr. CAGR %	-	41.79	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	106.1	28.81	-15.08	-37.33	-57.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	106.1	28.81	-15.08	-37.33	-57.4
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-13.89	-21.58
EBITA, 5 Yr. CAGR %	-	46.58	34.06	-13.29	-21.27
EBIT, 5 Yr. CAGR %	-	46.61	34.06	-13.29	-21.27
Earnings From Cont. Operations, 5 Yr. CAGR %	-	26.51	37.9	-13.11	-18.21
Net Income, 5 Yr. CAGR %	-	26.51	37.9	-13.11	-18.21
Normalized Net Income, 5 Yr. CAGR %	-	47.05	33.97	-17.65	-21.78
Diluted EPS Before Extra, 5 Yr. CAGR %	-	1.12	17.23	-20.06	-21.88
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	51.5	-26.63
Total Assets, 5 Yr. CAGR %	-	65.26	8.95	-3.39	-11.14
Tangible Book Value, 5 Yr. CAGR %	-	71.4	5.28	-6.89	-14.72
Common Equity, 5 Yr. CAGR %	-	71.72	5.86	-6.39	-14.29
Cash From Operations, 5 Yr. CAGR %	-	55.82	36.76	-7.96	-26.55
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	34.15	-12.19	-37.4
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	34.15	-12.19	-37.4